These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 11086436)
21. [Evaluation of chemosensitivity testing by CD-DST, and TS and DPD activity in cases of colorectal liver]. Tono T; Takahashi H; Kanoh T; Nakano Y; Tamagaki S; Yasue A; Okada K; Matsui S; Iwazawa T; Yano H; Kinuta M; Okamura J; Monden T Gan To Kagaku Ryoho; 2001 Oct; 28(11):1523-6. PubMed ID: 11707970 [TBL] [Abstract][Full Text] [Related]
22. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers. Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162 [TBL] [Abstract][Full Text] [Related]
23. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer. Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648 [TBL] [Abstract][Full Text] [Related]
24. [Thymidylate synthase and dihydropyrimidine dehydrogenase gene expressions in colorectal cancer using the Danenberg tumor profile method]. Nagano H; Ichikawa W; Simizu M; Shirota Y; Nihei Z Gan To Kagaku Ryoho; 2004 Jun; 31(6):889-92. PubMed ID: 15222106 [TBL] [Abstract][Full Text] [Related]
25. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Jiang W; Lu Z; He Y; Diasio RB Clin Cancer Res; 1997 Mar; 3(3):395-9. PubMed ID: 9815697 [TBL] [Abstract][Full Text] [Related]
26. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer]. Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer. Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608 [TBL] [Abstract][Full Text] [Related]
29. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer]. Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381 [TBL] [Abstract][Full Text] [Related]
30. Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer. Uetake H; Ichikawa W; Takechi T; Fukushima M; Nihei Z; Sugihara K Clin Cancer Res; 1999 Oct; 5(10):2836-9. PubMed ID: 10537350 [TBL] [Abstract][Full Text] [Related]
31. 5-Fluorouracil-related gene expression in primary sites and hepatic metastases of colorectal carcinomas. Sameshima S; Tomozawa S; Kojima M; Koketsu S; Motegi K; Horikoshi H; Okada T; Kon Y; Sawada T Anticancer Res; 2008; 28(3A):1477-81. PubMed ID: 18630501 [TBL] [Abstract][Full Text] [Related]
32. Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer. Tsuji T; Sawai T; Takeshita H; Nakagoe T; Hidaka S; Yamaguchi H; Yasutake T; Nagayasu T; Tagawa Y Cancer Chemother Pharmacol; 2004 Dec; 54(6):531-6. PubMed ID: 15309506 [TBL] [Abstract][Full Text] [Related]
33. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma. Sasaki H; Fukai I; Kiriyama M; Kaji M; Yano M; Yamakawa Y; Fujii Y Surg Today; 2003; 33(2):83-8. PubMed ID: 12616366 [TBL] [Abstract][Full Text] [Related]
34. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer]. Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H; Iinuma H; Watanabe T Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408 [TBL] [Abstract][Full Text] [Related]
36. Population study of expression of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with solid tumors. Fukushima M; Morita M; Ikeda K; Nagayama S Int J Mol Med; 2003 Dec; 12(6):839-44. PubMed ID: 14612954 [TBL] [Abstract][Full Text] [Related]
37. Dihydropyrimidine dehydrogenase activity and thymidylate synthase level are associated with response to 5-fluorouracil in human colorectal cancer. Araki Y; Isomoto H; Shirouzu K Kurume Med J; 2001; 48(2):93-8. PubMed ID: 11501504 [TBL] [Abstract][Full Text] [Related]
38. [A preliminary study on dihydropyrimidine dehydrogenase activity in breast cancer]. Hamaji M; Miyazaki S; Nishida Y; Izukura M; Nishijima J; Oka Y; Seshimo I; Ohwari M Gan To Kagaku Ryoho; 2000 Oct; 27(11):1719-24. PubMed ID: 11057323 [TBL] [Abstract][Full Text] [Related]
39. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer. Inoue T; Hibi K; Nakayama G; Komatsu Y; Fukuoka T; Kodera Y; Ito K; Akiyama S; Nakao A J Gastroenterol; 2005 Feb; 40(2):143-7. PubMed ID: 15770397 [TBL] [Abstract][Full Text] [Related]
40. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]